¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"complementary interaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complementary afterimage
    º¸»öÀÜ»ó
  • complementary and alternative medicine
    º¸Ãæ´ë¾ÈÀÇÇÐ, º¸¿Ï´ëüÀÇÇÐ
  • complementary color
    º¸»ö
  • complementary factor
    º¸ÃæÀÎÀÚ
  • complementary feeding
    º¸Ã濵¾ç
  • complementary gene
    º¸Á·À¯ÀüÀÚ, »óÈ£º¸ÃæÀ¯ÀüÀÚ
  • complementary medicine
    º¸¿ÏÀÇÇÐ
  • complementary pair
    º¸Ã¼Â¦
  • antigen-antibody interaction
    Ç׿øÇ×ü»óÈ£ÀÛ¿ë
  • additive interaction
    »ó°¡ÀÛ¿ë
  • binocular interaction
    µÎ´«»óÈ£ÀÛ¿ë, ¾ç¾È»óÈ£ÀÛ¿ë
  • cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ë
  • drug interaction
    ¾à¹°»óÈ£ÀÛ¿ë
  • dipolar interaction
    ½Ö±ØÀÚ»óÈ£ÀÛ¿ë
  • genetic interaction
    À¯Àü»óÈ£ÀÛ¿ë
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interaction
    »óÈ£ÀÛ¿ë
  • complementary medicine
    º¸¿ÏÀÇÇÐ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complementary afterimage
    º¸»öÀÜ»ó
  • complementary
    º¸Á·-, º¸Ã¼-, µµ¿òü-
  • complementary color
    º¸»ö
  • complementary factor
    º¸ÃæÀÎÀÚ, º¸Ã¼ÀÎÀÚ
  • complementary feeding
    º¸Ã濵¾ç
  • complementary gene
    º¸Á·À¯ÀüÀÚ, »óÈ£º¸ÃæÀ¯ÀüÀÚ
  • complementary nucleotide
    »óº¸´ºÅ¬·¹¿ÀƼµå
  • complementary pair
    º¸ÇÕ¦
  • additive interaction
    »ó°¡ÀÛ¿ë
  • antigen-antibody interaction
    Ç׿øÇ×ü¹ÝÀÀ
  • binocular interaction
    ¾ç¾È»óÈ£ÀÛ¿ë, µÎ´«»óÈ£ÀÛ¿ë
  • cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ë
  • dipolar interaction
    ½Ö±ØÀÚ»óÈ£ÀÛ¿ë
  • drug interaction
    ¾à¹°»óÈ£ÀÛ¿ë
  • genetic interaction
    À¯Àü»óÈ£ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • J-coupling interaction
    J °áÇÕ »óÈ£ÀÛ¿ë
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • additive interaction
    »ó°¡(ßÓÊ¥)ÀÛ¿ë.
  • antigen antibody interaction
    Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
  • antigen antibody interaction
    Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
  • antigen antibody interaction
    Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
  • antigen-antibody interaction
    Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
  • genetic interaction
    À¯ÀüÀû »óÈ£ÀÛ¿ë
  • heme heme interaction
    Èû-Èû »óÈ£ÀÛ¿ë(¡­ßÓû»íÂéÄ).
  • heme heme interaction
    Çð-Çð »óÈ£ÀÛ¿ë(¡­ßÓû»íÂéÄ).
  • infant-mother interaction
    ¿µ¾Æ-¸ð »óÈ£ÀÛ¿ë
  • interaction
    »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ).
  • interaction
    »óÈ£ÀÛ¿ë
  • interaction, T-B cell
    T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
  • interaction, T-T cell
    T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • base pair, complementary
    »óº¸¼º ¿°±â½Ö
  • complementary
    º¸Á·(¼º)(ÜÍðëàõ)ÀÇ, º¸Ã¼(¼º)ÀÇ.
  • complementary afterimage
    º¸»öÀÜ»ó
  • complementary air =inspiratory reserve volume
    ¿¹ºñÈí±â·®(çãÝáýåѨåÖ) .
  • complementary colo(u)r
    º¸»ö(ÜÍßä).
  • complementary color
    º¸»ö
  • complementary factor
    º¸ÃæÀÎÀÚ(¡­ì×í­), º¸Ã¼ÀÎÀÚ.
  • complementary feeding
    º¸Ã濵¾ç(¡­ç½å×).
  • complementary gene
    º¸Á·À¯ÀüÀÚ(ÜÍðëë¶îîí­), º¸Ã¼À¯ÀüÀÚ.
  • complementary genes
    »óº¸¼ºÀ¯ÀüÀÚ(ßÀÜÍàõë¶îîí­).
  • complementary male
    º¸¿õ(ÜÍê©).
  • complementary nucleotides
    ´ë»ó¼º´ºÅ¬·¹¿ÀŸÀ̵å
  • complementary pair
    º¸ÇÕ¦.
  • complementary replacement
    º¸Á·¼º ġȯ»ó(ÜÍðëàõöÇüµßÀ).
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complementary interaction
    »óº¸¼º »óÈ£ÀÛ¿ë(ßÓÜÍàõßÓû»íÂéÄ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complementary base pairing
    »óº¸¼º(ßÓÜÍàõ) ¿°±â(ç¤Ðñ) ¦Áþ±â
  • complementary base sequence
    »óº¸¼º ¿°±â¼­¿­(ßÓÜÍàõç¤ÐñßíÖª)
  • complementary DNA
    »óº¸¼º(ßÓÜÍàõ) DNA
  • complementary genes
    »óº¸¼º À¯ÀüÀÚ(ßÓÜÍàõë¶îîí­)
  • complementary RNA
    »óº¸¼º(ßÓÜÍàõ) RNA
  • complementary strand
    »óº¸¼º(ßÓÜÍàõ) °¡´Ú
  • crossed hydrophobic interaction immunoelectrophoresis ±³Â÷ ¼Ò¼ö¼º»óÈ£ÀÛ¿ë ¸é¿ªÀü±â¿µµ¿(Îßó©áÂâ©àõßÓû»íÂéÄØóæ¹ï³Ñ¨ç¶
    ÔÑ)
  • dipole-dipole interaction
    ½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ÀÛ¿ë(äªÐ¿í­äªÐ¿í­ßÓû»íÂéÄ)
  • dipole-induced dipole interaction
    ½Ö±ØÀÚÀ¯µµ ½Ö±ØÀÚ »óÈ£ÀÛ¿ë(äªÐ¿í­ë¯ÓôäªÐ¿í­ßÓû»íÂéÄ)
  • hydrophobic interaction
    ¼Ò¼ö »óÈ£ÀÛ¿ë(áÂâ©ßÓû»íÂéÄ)
  • hydrophobic interaction chromatography
    ¼Ò¼ö »óÈ£ÀÛ¿ë(áÂâ©ßÓû»íÂéÄ) Å©·Î¸¶Åä±×·¡ÇÇ
  • ion-dipole interaction
    ÀÌ¿Â-½Ö±ØÀÚ(äªÐ¿í­) »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • ion induced dipole interaction
    "ÀÌ¿ÂÀ¯µµ(ë¯Óô) ½Ö±ØÀÚ(äªÐ¿í­), »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)"
  • ion-ion interaction
    ÀÌ¿Â-À̿ »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • long-range interaction
    ¿ø°Å¸® »óÈ£ÀÛ¿ë(êÀËå×îßÓû»íÂéÄ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dipolar interaction
    ½Ö±ØÀÚ»óÈ£ÀÛ¿ë
  • dipole dipole interaction
    ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£ÀÛ¿ë
  • intermolecular dipole dipole interaction
    ºÐÀÚ°£½Ö±ØÀÚ°£»óÈ£ÀÛ¿ë
  • intramolecular dipole dipole interaction
    ºÐÀÚ³»½Ö±ØÀÚ°£»óÈ£ÀÛ¿ë
  • J-coupling interaction
    J°áÇÕ»óÈ£ÀÛ¿ë
  • proton electron dipole dipole interaction
    ¾çÀÚÀüÀÚ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£¹ÝÀÀ
  • proton proton dipole dipole interaction
    ¾çÀÚ¾çÀÚ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£¹ÝÀÀ
  • tissue interaction
    Á¶Á÷°£ÀÇ »óÈ£ÀÛ¿ë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CMOS Complementary Metal Oxide Semiconductor
cDNA circular deoxyribonucleic acid; complementary deoxyribonucleic acid
CDR calcium-dependent regulator; clinical dementia rating; complementary determining region; computerize...
CMOS complementary metal-oxide semiconductor
MORAC mixed oligonucleotides primed amplification of complementary deoxyribonucleic acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
c Complementary
cDNA Complementary DNA
CM Complementary Medicine
cRNA Complementary RNA
CAM Complementary and Alternative Medicine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • complementary afterimage
    º¸»ö ÀÜ»ó
  • complementary base pair
    »óº¸¼º ¿°±â½Ö
  • complementary factor
    º¸Ãæ ÀÎÀÚ
  • complementary male
    º¸¿õ
  • abnormality of cell interaction
    ¼¼Æ÷ »óÈ£ÀÛ¿ë ÀÌ»ó
    ¼¼Æ÷ »çÀÌ¿¡ ÀϾ´Â ÀÛ¿ëÀÌ ºñÁ¤»óÀûÀÎ °Í.
  • additive interaction
    »ó°¡ ÀÛ¿ë
  • heme heme interaction
    Èû-Èû »óÈ£ÀÛ¿ë
  • high-power interaction
    °íÃâ·Â »óÈ£ ÀÛ¿ë
  • interaction
    »óÈ£ ÀÛ¿ë
    µÎ °³ ¶Ç´Â ±× ÀÌ»óÀÌ ¼­·Î ¼­·Î ÀÛ¿ëÇÏ´Â ¼ºÁú, »óųª °úÁ¤.
  • nonthermal interaction
    ºñ¿­ »óÈ£ÀÛ¿ë
  • photochemical interaction
    ±¤È­ÇÐ ¹ÝÀÀ
  • photothermal interaction
    ±¤¿­ ¹ÝÀÀ
  • proton proton dipole dipole interaction
    ¾çÀÚ ¾çÀÚ ½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ ¹ÝÀÀ
  • triple interaction
    »ïÁß »óÈ£ ÀÛ¿ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
apolar interaction <chemistry> The attractive force between molecules due to the close positioning of non-hydrophilic portions of the two molecules.
(09 Oct 1997)
hydrophobic interaction <chemistry> The attractive force between molecules due to the close positioning of non-hydrophilic portions of the two molecules.
(09 Oct 1997)
specimen interaction <microscopy> Reactions that occur inside the specimen when being struck with a beam of energetic electrons or ions.
(05 Aug 1998)
specimen interaction volume <microscopy> The volume inside the specimen in which all specimen interactions occur during electron beam irradiation.
(05 Aug 1998)
DNA-protein interaction <molecular biology> Any complex that forms between a protein molecule and DNA.
Examples are nucleosomes (structures formed for the purpose of DNA storage) and any gene regulatory protein (a protein which regulates transcription by binding to a regulatory region on the DNA).
(09 Oct 1997)
drug-drug interaction The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity.
(09 Oct 1997)
drug interaction <pharmacology> A chemical or physiologic reaction that can occur when two different medications are taken together and the interaction may affect the metabolism, effectiveness or toxicity of the other.
(18 Jul 2002)
interaction The quality, state or process of (two or more things) acting on each other.
(18 Nov 1997)
interaction process analysis In psychology, analysis of small group behaviour in terms of 12 specific categories, e.g., solidarity, tension release, agreement.
(05 Mar 2000)
RNA, complementary Synthetic transcripts of a specific DNA molecule or fragment, made by an in vitro transcription system. This crna can be labelled with radioactive uracil and then used as a probe.
(12 Dec 1998)
complementary Supplying a defect or helping to do so, making complete, accessory.
Origin: L. Complere = to fill
(18 Nov 1997)
complementary air The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the tidal volume and the inspiratory reserve volume. Common abbreviation is ic.
(12 Dec 1998)
complementary base pairing <molecular biology> The pairing of complementary nucleotide bases (adenine and thymine, guanine and cytosine) to each other via hydrogen bonds from opposite strands of a double stranded nucleic acid (such as DNA or RNA), thereby holding the double-stranded nucleic acid together.
(09 Oct 1997)
complementary base pairs <molecular biology> The crucial property of DNA is that the two strands are complementary: Guanine and cytosine are complementary and pair up through their hydrogen bonds, as are adenine and thymine that only form two hydrogen bonds. (adenine and uracil in RNA).
(18 Nov 1997)
complementary colours Pairs of different colours of light that produce white light when combined.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interaction
    »óÈ£ÀÛ¿ë
  • drug interaction
    (¾à)¾à¹° »óÈ£ ÀÛ¿ë
  • interaction
    »óÈ£ÀÛ¿ë;»óÈ£ÀÇ ¿µÇâ
  • complementary
    º¸ÃæÀûÀÎ
  • complementary
    º¸¿ÏÀûÀÎ;¼­·Î º¸¿ÏÇÏ´Â;º¸»ö;-tarily
  • complementary angle
    ¿©°¢
  • complementary cell
    º¸Á· ¼¼Æ÷
  • complementary color
    º¸»ö !
  • complementary distribution
    »óº¸ ºÐÆ÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á